Home › Funds › Michelson Medical Research Foundation, Inc. › IBB
Michelson Medical Research Foundation, Inc. position in IBB
ISHARES TR
Michelson Medical Research Foundation, Inc. reported holding 35,095 shares of IBB (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 6.57% of its reported portfolio and ranking #6 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed IBB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Michelson Medical Research Foundation, Inc.'s IBB position evolved
Michelson Medical Research Foundation, Inc. first disclosed a stake in IBB in Q3 2023 at 43,395 shares (US$5.3M). The position peaked in Q3 2026 at 35,095 shares, worth US$7.4M. Across 13 filings, Michelson Medical Research Foundation, Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 35,095 shares valued at US$7.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 43.40K | $5.31M | New |
| Q4 2023 | 43.40K | $5.90M | Hold |
| Q1 2024 | 43.40K | $5.95M | Hold |
| Q2 2024 | 43.40K | $5.96M | Hold |
| Q3 2024 | 43.40K | $6.32M | Hold |
| Q4 2024 | 43.40K | $5.74M | Hold |
| Q1 2025 | 43.40K | $5.55M | Hold |
| Q2 2025 | 35.09K | $4.44M | Reduce |
| Q3 2025 | 35.09K | $5.07M | Hold |
| Q4 2025 | 35.09K | $5.92M | Hold |
| Q1 2026 | 35.09K | $5.93M | Hold |
| Q2 2026 | 35.09K | $6.67M | Hold |
| Q3 2026 | 35.09K | $7.39M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IBB and 13F data
IBB (ISHARES TR) is a company whose sector is not yet classified in our data. 26 other funds we track also report a position in IBB — the largest reported positions include Citigroup Inc (US$963.2M), BNP PARIBAS FINANCIAL MARKETS (US$517.8M), COMMERCE BANK (US$190.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IBB
- Citigroup Inc 4.58M sh · $963.19M · Q3 2026
- BNP PARIBAS FINANCIAL MARKETS 2.46M sh · $517.79M · Q3 2026
- COMMERCE BANK 902.61K sh · $190.03M · Q3 2026
- WestEnd Advisors, LLC 563.56K sh · $118.65M · Q3 2026
- Jefferies Financial Group Inc. 417.50K sh · $87.90M · Q3 2026
More on Michelson Medical Research Foundation, Inc.
FAQ
How long has Michelson Medical Research Foundation, Inc. held IBB?
Michelson Medical Research Foundation, Inc. has disclosed IBB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Michelson Medical Research Foundation, Inc.'s current position in IBB?
As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 35.09K shares of IBB (ISHARES TR), valued at $7.39M, representing 6.57% of its reported portfolio and ranking #6.
Has Michelson Medical Research Foundation, Inc. been buying or selling IBB?
In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in IBB. The position peaked in Q3 2026 at 35.09K shares.
Which other funds hold IBB?
Other major institutional holders of IBB include Citigroup Inc, BNP PARIBAS FINANCIAL MARKETS, COMMERCE BANK, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.